IMDX CIK: 1642380

Insight Molecular Diagnostics Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.9
FY22:
−45.6
FY23:
−23.3
FY24:
−20.7
FY25:
−22.2
Change from FY21 to FY25
millions USD
FY21:
−14.0
FY22:
−4.34
FY23:
−0.93
FY24:
−0.51
FY25:
−3.19
Change from FY21 to FY25
millions USD
FY21:
78.4
FY22:
35.8
FY23:
12.2
FY24:
20.4
FY25:
28.1
millions USD
FY21:
28.5
FY22:
−14.1
FY23:
−12.1
FY24:
−0.80
FY25:
2.58
(positive)
Change from FY21 to FY25
millions USD
FY21:
−38.2
FY22:
−49.9
FY23:
−23.6
FY24:
−21.2
FY25:
−25.4

All amounts in millions USD Data source:SEC EDGAR